全文获取类型
收费全文 | 30867篇 |
免费 | 1241篇 |
国内免费 | 1068篇 |
专业分类
耳鼻咽喉 | 1532篇 |
儿科学 | 844篇 |
妇产科学 | 563篇 |
基础医学 | 950篇 |
口腔科学 | 782篇 |
临床医学 | 2293篇 |
内科学 | 2592篇 |
皮肤病学 | 233篇 |
神经病学 | 1254篇 |
特种医学 | 943篇 |
外国民族医学 | 4篇 |
外科学 | 12692篇 |
综合类 | 3734篇 |
预防医学 | 1147篇 |
眼科学 | 392篇 |
药学 | 1571篇 |
11篇 | |
中国医学 | 174篇 |
肿瘤学 | 1465篇 |
出版年
2024年 | 35篇 |
2023年 | 497篇 |
2022年 | 824篇 |
2021年 | 1108篇 |
2020年 | 992篇 |
2019年 | 1101篇 |
2018年 | 1092篇 |
2017年 | 834篇 |
2016年 | 942篇 |
2015年 | 1007篇 |
2014年 | 1995篇 |
2013年 | 1753篇 |
2012年 | 1913篇 |
2011年 | 2191篇 |
2010年 | 2071篇 |
2009年 | 2051篇 |
2008年 | 1845篇 |
2007年 | 1847篇 |
2006年 | 1590篇 |
2005年 | 1430篇 |
2004年 | 1116篇 |
2003年 | 917篇 |
2002年 | 804篇 |
2001年 | 619篇 |
2000年 | 409篇 |
1999年 | 298篇 |
1998年 | 236篇 |
1997年 | 188篇 |
1996年 | 189篇 |
1995年 | 133篇 |
1994年 | 122篇 |
1993年 | 93篇 |
1992年 | 63篇 |
1991年 | 70篇 |
1990年 | 63篇 |
1989年 | 39篇 |
1988年 | 37篇 |
1987年 | 38篇 |
1986年 | 47篇 |
1985年 | 73篇 |
1984年 | 71篇 |
1983年 | 51篇 |
1982年 | 47篇 |
1981年 | 41篇 |
1980年 | 49篇 |
1979年 | 50篇 |
1978年 | 51篇 |
1976年 | 30篇 |
1975年 | 33篇 |
1974年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
《Revista espa?ola de anestesiología y reanimación》2022,69(9):517-525
Background and objectivesThe ideal timing of tranexamic acid administration in total knee arthroplasty with tourniquet remains unclear. Our primary objective was to prove if administering it before surgical incision, instead of before releasing the tourniquet, reduces postoperative bleeding. A second objective was to determine whether a second dose reduces post-operative bleeding.Material and methodsA prospective, double-blind clinical trial was performed on 212 patients scheduled for total knee arthroplasty. They were randomised into 4 groups. Tranexamic acid was administered before the surgical incision in “pre-induction groups” (1 and 2), and just before the tourniquet release in “pre-release groups” (3 and 4). Groups 2 and 4 received a second dose 3 hours post-surgery. Main outcome was postoperative bleeding (visible blood loss and calculated total bleeding). Secondary outcomes were haemoglobin variations, complications and transfusion rate.ResultsThe mean calculated total bleeding was 1563 ml (95%CI: 1445 to 1681) in preinduction groups versus 1576 ml (95%CI: 1439 to 1713) in pre-release groups (P = .9); 1579 ml (95%CI: 1452 to 1706) in single-dose groups versus 1559 ml (95%CI: 1431 to 1686) in double-dose groups (P = .82). One patient was transfused. The mean haemoglobin at discharge was 10.4 g/dl (95%CI: 10.2 to 10.7) in singledose groups versus 10.8 (95%CI: 10.6 to 11.1) in double-dose groups (P = .06).ConclusionsThere were no differences in bleeding or transfusion regarding the time of tranexamic acid administration. The second dose had not impact on outcomes.Trial registration: EudraCT 2016-000071-24. 相似文献
42.
《European journal of surgical oncology》2020,46(6):1138-1143
IntroductionThe purpose of this study was to review recommendations made from a specialist pelvic exenteration (PE) multidisciplinary team (MDT) and to provide insights as to the impact of the MDT on patient selection and clinical decision making.Materials & methodsA retrospective review was conducted at Royal Prince Alfred Hospital's PE MDT between June 2014 and December 2015. Data was collected from the recorded minutes of MDT meetings. Referral information and clinical data was extracted from individual patient files. Additional data including operative dates and surgical resection margins were collected from electronic medical records.ResultsOf the 183 patients considered for PE during the MDT meeting, 104 (57%) were recommended for surgery. Factors that influenced the recommendation in favour of surgery were referral by a surgeon (P = 0.004), referral from a rural location (P = 0.05) and having locally advanced primary cancer (P < 0.001). Patients who were seen by the unit's surgeon prior to the MDT did not impact on the MDT recommendation nor the decision for or against surgery (P = 0.771). The most common reason for recommendation against PE was unresectable distant metastatic disease (43%).ConclusionsThe PE MDT meeting is a critical step in the patient care pathway and facilitates critical decision making. Anatomically-based contraindications to surgery (i.e. involvement of adjacent organs, bone and neurovascular structures) do not appear to influence MDT decision making regarding resectability. 相似文献
43.
44.
45.
46.
47.
《Journal of Clinical Orthopaedics and Trauma》2020,11(3):357-368
BackgroundCharcot neuroarthropathy is a complex condition characterised by progressive deformity, limited treatment options and a high amputation rate. Surgical reconstruction of Charcot foot has been proposed as a method to preserve the foot. However, limited information exists on the different methods of reconstruction available, their outcomes and complications.MethodsWe systematically analysed published data from Jan 1993 to Dec 2018 to assess methods of fixation and associated outcomes for the surgical reconstruction in Charcot neuroarthropathy. Statistical analyses were undertaken to determine the amputation rates, return to ambulation and complications associated with these techniques.ResultsA total of 1116 feet (1089 patients) were reported to have undergone reconstruction with significant heterogeneity in patient selection. Of these, 726 (65%) were reported to undergo internal fixation, 346 feet (31%) external fixation and 44 (4%) undergoing simultaneous internal and external fixation. No single technique demonstrated a significant benefit over the other. Overall, the bone fusion rate was 86.1%. Complications directly attributable to the technique employed were noted in 36% of individuals. The reported post-reconstruction amputation rate was only 5.5% with 91% apparently returning to ambulation.ConclusionsAlthough no preferential method of fixation was identified, we find that the current options for surgical reconstruction could offer limb salvage with a low amputation risk in a highly selected population. However, the lack of controlled studies, inconsistent reporting of outcomes and heterogeneity of patient selection mean that the quality of evidence is low. 相似文献
48.
49.
BackgroundDespite the potential benefits, the adoption of the minimally invasive surgery for the treatment of borderline resectable pancreatic cancer is still in the initial phase. We investigated the safety and feasibility of the robotic pancreaticoduodenectomy with venous resection/reconstruction (RPD SMV/PV).MethodsSince March 2013 to October 2019, a total of 73 RPD and 10 RPD SMV/PV were performed. The two groups were case-matched according to the preoperative characteristics.ResultsMean operative times and estimated blood loss were less in the RPD group in comparison to that in the RPD with SMV-PV group (525 vs 642 min, p = 0.003 and 290 vs 620 ml, p = 0.002, respectively). The mean length of hospital stay was similar in the RPD group in comparison to that in the RPD with SMV-PV group (10 days vs 13 days, p = 0.313). The two groups had similar overall postoperative morbidity rate (57.5% vs 60%, p = 0.686), although the severe complication rate was lower in the RPD group (11% vs 40%, p = 0.004).ConclusionsRPD with SMV-PV is associated with increased operative time, estimated blood loss, higher major complication rate compared with RPD. 相似文献
50.